Circulating miR-378 is increase in blood serum of renal cell carcinoma patients
| Authors | |
|---|---|
| Year of publication | 2013 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | Renal cell carcinoma is the most common neoplasm of adult kidney, having the highest mortality rate at over 40%. Renal tumors are commonly asymptomatic in early stages and although surgical resection remains the best therapy, after the curative nephrectomy 20-40% of patients will develop recurrence. Our aim was to identify serum biomarkers, which could be used for diagnosis or early detection of recurrence in renal cell carcinoma patients. |
| Related projects: |
|